Look at the connections here in the U.S. and Canada.....
In the past five years, the Group has established strategic partnerships with a number of universities in biomedicine in Toronto, Montreal, Boston, New York and Connecticut, and has established extensive government resource management and business contacts. Relationships have now resulted in multiple levels of investment for more than 20 projects. In Toronto, Montreal and New York, it has invested more than 50 million yuan to screen the world's first-class projects in the biomedical industry.
The four major international projects that have been introduced:
Gene-coated cardiac stent from McGill University, Canada, hepatitis B virus cure vaccine from Yale University, male infertility detection technology at Mount Sinai Hospital, Canada, and the American Maiwei Stroke Clearing Project. The global production bases of the four major projects will be located in the Jinan High-tech Zone. After the project is matured, it will be built in Jinan Pharmaceutical Valley and Life Science City for 5-7 years to build a world-class biomedical industrial park. The park plans to acquire 500 mu of land and gradually establish five multi-functional parks: biomedical incubator and medium Test Base Park; Pharmaceutical Logistics and Pharmaceutical Products Trade Complex; Innovative Medicine and Medical Devices, Consumables and Health Products Industrial Park; International Cardiovascular and Rehabilitation Park; Established Talent Training Base with University of Toronto, Tsinghua University and Shandong University - Pharmaceutical Business School Campus.
In October 2015, the first “ China - Canada Biomedical New Technology Cooperation Forum ” was held in Jinan, Shandong Province with Harvard University, Massachusetts Institute of Technology, Yale University, University of Michigan, McGill University, University of Toronto, McMahon. The University of Queens, Queen's University, Bethune Medical Development Association and other units have jointly established the " China - North America Innovation Medical Investment and Industry Alliance " , which brings the world's most advanced biomedical technology to China and promotes the national pharmaceutical industry with technological innovation. development of. The forum is held once a year.
In the next five years of development, the group company will be based in Shandong, focus on North America, cooperate in research and development of new technologies from the innovation of the pharmaceutical industry chain, introduce a number of world-class projects, and establish a nationwide Greater China marketing management platform in the distribution agency market. In the hospital terminal market, establish a platform for the professional chain hospital with reasonable technology and reasonable operation.